Results for “Esprit™ BTK Everolimus Eluting Resorbable Scaffold System”

Name, manufacturer or identifier

Manufacturer (optional)

Filters

Registry EUDAMED FDA 510(k) incl. De Novo FDA PMA GUDID

Country / market European Union (all) United States

More countries (18)

Germany Italy Türkiye France Netherlands Spain Austria Poland Belgium Ireland Czechia Portugal Greece Sweden Hungary Denmark Romania Liechtenstein

Risk class Class I Class IIa Class IIb Class III Class II (US)

More classes (11)

Class A Class B Class C Class D IVD General IVD Annex II List A IVD Annex II List B IVD for self-testing Active implantable (AIMDD) Unclassified (FDA) Not classified (FDA)

Verified Verified only

Category (EMDN)

Browse by category

129 devices foundsorted by relevance

Clear all

DeviceDevice · Manufacturer · Authorizations Verified

Status

Regime

Registry

Class

Esprit™ BTK Everolimus Eluting Resorbable Scaffold System

Abbott Medical,United States Group of variants

Active Regimes: CE MDR Registry: EUDAMED Class:III
Esprit™ BTK Everolimus Eluting Resorbable Scaffold System

Abbott Medical,United States

Active Regimes: PMA Registry: PMA Class:III

Previous Next

Showing 121-129 of 129

deviCERTS Global Medical Device Regulatory Database

About [email protected]